VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+3.91%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$245M
AUM Growth
+$31M
(+15%)
Cap. Flow
+$30.8M
Cap. Flow
% of AUM
12.58%
Top 10 Holdings %
Top 10 Hldgs %
7.31%
Holding
511
New
57
Increased
251
Reduced
151
Closed
49
Top Buys
| 1 |
SPDR Bloomberg High Yield Bond ETF
JNK
|
$1.88M |
| 2 |
DocuSign
DOCU
|
$1.49M |
| 3 |
United Airlines
UAL
|
$1.47M |
| 4 |
Fortinet
FTNT
|
$1.35M |
| 5 |
Spotify
SPOT
|
$1.34M |
Top Sells
| 1 |
Applovin
APP
|
$1.45M |
| 2 |
Expedia Group
EXPE
|
$1.04M |
| 3 |
KKR & Co
KKR
|
$976K |
| 4 |
CME Group
CME
|
$974K |
| 5 |
Corpay
CPAY
|
$948K |
Sector Composition
| 1 | Financials | 29.48% |
| 2 | Technology | 14.86% |
| 3 | Healthcare | 14.81% |
| 4 | Industrials | 11.61% |
| 5 | Consumer Discretionary | 6.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CURB
326
Curbline Properties Corp.
CURB
$2.41B
| $139K | 0.06% |
+6,005
| New | +$139K |
|
327
Crown Castle
CCI
$41.9B
| $139K | 0.06% |
1,533
-161
| -10% | -$14.6K |
|
328
National Storage Affiliates Trust
NSA
$2.56B
| $138K | 0.06% |
3,641
-242
| -6% | -$9.17K |
|
329
American Tower
AMT
$92.9B
| $138K | 0.06% |
752
-89
| -11% | -$16.3K |
|
330
Berry Corp
BRY
$249M
| $135K | 0.06% |
32,690
+6,563
| +25% | +$27.1K |
|
331
Rexford Industrial Realty
REXR
$10.2B
| $134K | 0.05% |
3,459
-228
| -6% | -$8.81K |
|
332
B2Gold
BTG
$5.52B
| $128K | 0.05% |
52,324
-9,066
| -15% | -$22.1K |
|
333
TIM SA
TIMB
$10.3B
| $123K | 0.05% |
10,434
-906
| -8% | -$10.7K |
|
334
Companhia Siderúrgica Nacional
SID
$1.99B
| $122K | 0.05% |
85,026
+16,414
| +24% | +$23.6K |
|
|
XIFR
335
XPLR Infrastructure, LP
XIFR
$976M
| $116K | 0.05% |
6,543
+738
| +13% | +$13.1K |
|
336
Innovative Industrial Properties
IIPR
$1.61B
| $86.4K | 0.04% |
1,297
-206
| -14% | -$13.7K |
|
337
uniQure
QURE
$985M
| $83.4K | 0.03% |
4,721
-12,835
| -73% | -$227K |
|
338
Omeros
OMER
$284M
| $82.7K | 0.03% |
+8,373
| New | +$82.7K |
|
339
Zymeworks
ZYME
$1.14B
| $82.5K | 0.03% |
5,633
-4,481
| -44% | -$65.6K |
|
340
Annexon
ANNX
$238M
| $80.9K | 0.03% |
15,763
+424
| +3% | +$2.18K |
|
341
Arcutis Biotherapeutics
ARQT
$2.06B
| $80.8K | 0.03% |
5,803
-4,064
| -41% | -$56.6K |
|
342
Tango Therapeutics
TNGX
$772M
| $77.1K | 0.03% |
24,945
+13,961
| +127% | +$43.1K |
|
343
Praxis Precision Medicines
PRAX
$986M
| $77K | 0.03% |
1,001
-1,296
| -56% | -$99.7K |
|
344
Liquidia Corp
LQDA
$2.48B
| $75.9K | 0.03% |
6,457
-403
| -6% | -$4.74K |
|
345
Viridian Therapeutics
VRDN
$1.53B
| $75.8K | 0.03% |
3,952
-3,059
| -44% | -$58.6K |
|
346
CureVac
CVAC
$1.21B
| $75.8K | 0.03% |
22,216
-820
| -4% | -$2.8K |
|
347
Allogene Therapeutics
ALLO
$255M
| $75K | 0.03% |
35,194
-1,091
| -3% | -$2.32K |
|
|
SLN
348
Silence Therapeutics
SLN
$269M
| $74.1K | 0.03% |
10,772
+6,098
| +130% | +$42K |
|
349
Celcuity
CELC
$2.36B
| $73.8K | 0.03% |
5,638
-368
| -6% | -$4.82K |
|
350
Scholar Rock
SRRK
$3.02B
| $73.8K | 0.03% |
1,707
-8,064
| -83% | -$349K |
|